Description
The abstract identifies MST4 as the kinase phosphorylating LAMP2A to enhance CMA, but doesn’t explain what upstream signals activate MST4 in GSCs or why this occurs preferentially in cancer stem cells. Understanding this mechanism could reveal early intervention targets.
Gap type: unexplained_observation Source paper: Targeting chaperone-mediated autophagy inhibits properties of glioblastoma stem cells and restores anti-tumor immunity. (2026, Nature communications, PMID:41390755)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:33.548559+00:00”, “resolution_summary”: “Resolved by hypothesis hyp-lyso-snca-1d58cf205e1f: LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergic Neurons Create Selective Vulnerability to SNCA-Mediated CMA Blockade. Supporting evidence includes debate sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “hyp-lyso-snca-1d58cf205e1f”, “title”: “LAMP2A Liquid-Liquid Phase Separation Defects in Dopaminergic Neurons Create Selective Vulnerability to SNCA-Mediated CMA Blockade”, “score”: 0.307, “reason”: “5 token overlaps; entity overlap: cma, lamp2a”, “analysis_id”: null, “target_gene”: “LAMP2”, “target_pathway”: “CMA_pathway”, “disease”: “neurodegeneration”, “composite_score”: 0.7833, “confidence_score”: 0.68, “status”: “active”, “pubmed_evidence_ids”: [“29950142”, “35266854”, “37469132”, “39556016”, “40202173”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.462, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a_task_73907230”, “title”: “The study shows P2RY12 regulates VSMC foam cell formation but doesn’t explain what controls P2RY12 expression or activation in VSMCs during disease progression. Understanding these upstream regulators could reveal new therapeutic targets for vascular neurodegeneration.\n\nGap type: unexplained_observation\nSource paper: The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. (2021, Autophagy, PMID:32160082)”, “score”: 0.461, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041434-a4d6154a”, “quality_score”: 0.661, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-193244-89904941_20260416-035819”, “title”: “The abstract identifies APOE4’s primary effect on oligodendrocyte cholesterol metabolism but doesn’t explain the mechanistic pathway. Understanding this mechanism is critical for developing targeted therapeutics that address the root cause rather than downstream effects.\n\nGap type: unexplained_observation\nSource paper: APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes (2022, Nature, PMID:34788101)”, “score”: 0.44, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-193244-89904941”, “quality_score”: 0.69, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7_task_73907230”, “title”: “The abstract mentions multiple organelles synchronously present structural derangement in diseases like neurodegeneration, but doesn’t explain how mitophagy, reticulophagy, and other selective autophagy processes coordinate. Understanding this coordination is critical for therapeutic targeting.\n\nGap type: unexplained_observation\nSource paper: Organelle-specific autophagy in inflammatory diseases: a potential therapeutic target underlying the quality control of multiple organelles. (2021, Autophagy, PMID:32048886)”, “score”: 0.43, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062132-e71b3ef7”, “quality_score”: 0.8, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183021-c13d9f04”, “title”: “The abstract describes astrocyte phenotypic heterogeneity (A1/A2) but doesn’t explain the mechanistic switches governing this critical fate decision. Understanding these mechanisms is essential for therapeutic targeting of beneficial vs harmful astrocyte responses.\n\nGap type: unexplained_observation\nSource paper: Contribution of astrocytes to neuropathology of neurodegenerative diseases. (2021, Brain research, PMID:33516810)”, “score”: 0.428, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183021-c13d9f04”, “quality_score”: 0.66, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}